Baker Brothers Advisors - SUMMIT THERAPEUTICS INC ownership

SUMMIT THERAPEUTICS INC's ticker is SMMT and the CUSIP is 86627T108. A total of 87 filers reported holding SUMMIT THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.92 and the average weighting 0.0%.

Quarter-by-quarter ownership
Baker Brothers Advisors ownership history of SUMMIT THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$5,872,685
-62.9%
3,140,473
-50.2%
0.03%
-63.0%
Q2 2023$15,824,810
+43.4%
6,304,7050.0%0.09%
+53.3%
Q1 2023$11,033,234
+29.8%
6,304,705
+215.2%
0.06%
+17.6%
Q4 2022$8,500,0002,000,0000.05%
Other shareholders
SUMMIT THERAPEUTICS INC shareholders Q1 2023
NameSharesValueWeighting ↓
Virtus ETF Advisers LLC 50,714$94,8350.06%
Baker Brothers Advisors 3,140,473$5,872,6850.03%
VANCE WEALTH, INC. 39,266$73,4270.03%
CSS LLC/IL 258,814$483,9820.03%
SHELL ASSET MANAGEMENT CO 317,240$5930.02%
Steward Partners Investment Advisory, LLC 650,000$1,215,5000.02%
Alpine Global Management, LLC 30,000$56,1000.01%
HoyleCohen, LLC 74,408$139,1430.01%
BENDER ROBERT & ASSOCIATES 24,059$44,9900.01%
SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC 86,212$161,2160.01%
View complete list of SUMMIT THERAPEUTICS INC shareholders